Jessica M. Haddad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jessica M. Haddad has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Rachel Conrad
Harvard Medical School
2 shared publications Alice Hibara
Harvard College, Cambridge, USA
1 shared publicationAlison Chambers
Rhode Isl Hosp Lifespan Biostat Core, Providence, RI USA
1 shared publicationAlison Mosier-Mills
Harvard Medical School, Boston, USA
1 shared publicationAmy Brown
Department of Medical Oncology Hartford Healthcare Cancer Institute Hartford CT USA
1 shared publicationAshley Stuckey
Department of Obstetrics‐Gynecology, Women and Infants' Hospital Cancer Genetics and Prevention Program and The Breast Health Center Program in Women's Oncology The Warren Alpert Medical School of Brown University Providence RI USA
1 shared publication
Latest Publications
- 19 July 2024
- Published by Springer Nature
- p. 231-246
College Mental Health
- 20 July 2023
- Published by Springer Nature in Current Psychiatry Reports
- Vol. 25 (8) , 345-356
Responding to Suicide in School Communities: An Examination of Postvention Guidance from Expert Recommendations and Empirical Studies
Purpose of Review We review the published literature on a school’s response after a student dies by suicide (“postvention”). We examine published recommendations based on expert guidance and empirical studies that have evaluated postvention measures. Recent Findings Experts recommend careful communication with family, staff, and students that adheres to published suicide reporting guidelines. Experts also emphasize the importance of identifying and supporting high-risk students. Few robust, controlled studies have identified effective postvention measures. Effective measures tended to occur in group settings (e.g., group therapy), focus on improving grief symptoms, and involve mental health professionals. Summary Postvention has not been robustly studied in the school context. Expert recommendations and a few evidence-backed studies provide the frame for a coherent, school-based postvention response. Further research is needed to strengthen and expand our collective understanding of effective postvention measures in the school context as youth suicide attempts continue to rise.
- 20 July 2023
- Published by Springer Nature in Current Psychiatry Reports
- Vol. 25 (8) , 345-356
Responding to Suicide in School Communities: An Examination of Postvention Guidance from Expert Recommendations and Empirical Studies
Purpose of Review We review the published literature on a school’s response after a student dies by suicide (“postvention”). We examine published recommendations based on expert guidance and empirical studies that have evaluated postvention measures. Recent Findings Experts recommend careful communication with family, staff, and students that adheres to published suicide reporting guidelines. Experts also emphasize the importance of identifying and supporting high-risk students. Few robust, controlled studies have identified effective postvention measures. Effective measures tended to occur in group settings (e.g., group therapy), focus on improving grief symptoms, and involve mental health professionals. Summary Postvention has not been robustly studied in the school context. Expert recommendations and a few evidence-backed studies provide the frame for a coherent, school-based postvention response. Further research is needed to strengthen and expand our collective understanding of effective postvention measures in the school context as youth suicide attempts continue to rise.
- 12 October 2022
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 61 (10) , S201
2.57 Help-Seeking Attitudes and Behaviors in Asian American College Students
- 12 October 2022
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 61 (10) , S201
2.57 Help-Seeking Attitudes and Behaviors in Asian American College Students
- 6 October 2021
- Published by Springer Nature in Current Psychiatry Reports
- Vol. 23 (11) , 1-12
The Impact of Social Media on College Mental Health During the COVID-19 Pandemic: a Multinational Review of the Existing Literature
Purpose of Review During the COVID-19 pandemic, both social media use and rates of anxiety and depression among college students have increased significantly. This begs the question, what is the relationship between social media use and college student mental health during the COVID-19 pandemic? Recent Findings Prior studies have found mixed results regarding the relationship between social media use and college student mental health. This relationship has become increasingly complex during the COVID-19 pandemic. We found that excessive or problematic social media use during the COVID-19 pandemic was correlated with worse mental health outcomes that could be mitigated by dialectical thinking, optimism, mindfulness, and cognitive reappraisal. Summary The COVID-19 pandemic acts as a moderator by strengthening the relationship between social media use and mental health. Future studies should consider the impact of social media on college student mental health and concentrate on intervention initiatives to ensure the psychological well-being of college students during a global pandemic outbreak.
- 6 October 2021
- Published by Springer Nature in Current Psychiatry Reports
- Vol. 23 (11) , 1-12
The Impact of Social Media on College Mental Health During the COVID-19 Pandemic: a Multinational Review of the Existing Literature
Purpose of Review During the COVID-19 pandemic, both social media use and rates of anxiety and depression among college students have increased significantly. This begs the question, what is the relationship between social media use and college student mental health during the COVID-19 pandemic? Recent Findings Prior studies have found mixed results regarding the relationship between social media use and college student mental health. This relationship has become increasingly complex during the COVID-19 pandemic. We found that excessive or problematic social media use during the COVID-19 pandemic was correlated with worse mental health outcomes that could be mitigated by dialectical thinking, optimism, mindfulness, and cognitive reappraisal. Summary The COVID-19 pandemic acts as a moderator by strengthening the relationship between social media use and mental health. Future studies should consider the impact of social media on college student mental health and concentrate on intervention initiatives to ensure the psychological well-being of college students during a global pandemic outbreak.
- 27 April 2021
- Published by Wiley in Journal of Genetic Counseling
- Vol. 30 (6) , 1570-1581
Family planning in carriers of BRCA1 and BRCA2 pathogenic variants
BRCA1 and BRCA2 pathogenic variant carriers have a high lifetime risk of developing breast and ovarian malignancies. Given the risks and significant ramifications of undergoing risk‐reducing surgeries, many pathogenic variant carriers unaffected by cancer (previvors) struggle with family planning and reproductive decision making. The objective of this study was to determine the attitudes and practices of BRCA1 and BRCA2 pathogenic variant carriers with respect to family planning decision making. A cross‐sectional survey was conducted of BRCA1 and BRCA2 previvors at four Northeastern medical centers. The survey was administered electronically via email using REDCap. The survey included demographic information as well as questions about genetic testing, prophylactic surgeries, family planning, and partnering. Data were analyzed with Fisher's exact tests and t tests. The survey was completed by 139 of 422 BRCA1 and BRCA2 pathogenic variant carriers (response rate 33%). Thirteen were excluded from analysis due to self‐reported cancer history. Of the remaining 126, 21 (16.7%) were male and 105 (83.3%) were female. Female participants BRCA1 and BRCA2 pathogenic variant (p < 0.0001). Younger women also reported their genetic status had a stronger impact on their romantic relationships (p = 0.029). Men were significantly more likely to report that they felt no urgency to have a family compared to women (p < 0.0001). Our study reflects the complex decision making for previvors and the intricacies of family planning in this population. Providers can use this knowledge as a guide to counsel patients about reproductive options.
- 27 April 2021
- Published by Wiley in Journal of Genetic Counseling
- Vol. 30 (6) , 1570-1581
Family planning in carriers of BRCA1 and BRCA2 pathogenic variants
BRCA1 and BRCA2 pathogenic variant carriers have a high lifetime risk of developing breast and ovarian malignancies. Given the risks and significant ramifications of undergoing risk‐reducing surgeries, many pathogenic variant carriers unaffected by cancer (previvors) struggle with family planning and reproductive decision making. The objective of this study was to determine the attitudes and practices of BRCA1 and BRCA2 pathogenic variant carriers with respect to family planning decision making. A cross‐sectional survey was conducted of BRCA1 and BRCA2 previvors at four Northeastern medical centers. The survey was administered electronically via email using REDCap. The survey included demographic information as well as questions about genetic testing, prophylactic surgeries, family planning, and partnering. Data were analyzed with Fisher's exact tests and t tests. The survey was completed by 139 of 422 BRCA1 and BRCA2 pathogenic variant carriers (response rate 33%). Thirteen were excluded from analysis due to self‐reported cancer history. Of the remaining 126, 21 (16.7%) were male and 105 (83.3%) were female. Female participants BRCA1 and BRCA2 pathogenic variant (p < 0.0001). Younger women also reported their genetic status had a stronger impact on their romantic relationships (p = 0.029). Men were significantly more likely to report that they felt no urgency to have a family compared to women (p < 0.0001). Our study reflects the complex decision making for previvors and the intricacies of family planning in this population. Providers can use this knowledge as a guide to counsel patients about reproductive options.
- 1 February 2021
- Published by SLACK, Inc. in Psychiatric Annals
- Vol. 51 (2) , 88-94
Assessing How Violent Threats from Students Toward Schools Are Affected Before and After a School Shooting
- 1 February 2021
- Published by SLACK, Inc. in Psychiatric Annals
- Vol. 51 (2) , 88-94
Assessing How Violent Threats from Students Toward Schools Are Affected Before and After a School Shooting
- 20 May 2008
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 26 (15_suppl) , 14595
Integrated safety analysis of elesclomol (formerly STA-4783) co-administered with paclitaxel
14595 Background: Elesclomol is a novel small-molecule oxidative stress inducer known to synergize with taxanes and certain other chemotherapeutics. Co-administered with paclitaxel (E+P), it demonstrated encouraging activity in metastatic melanoma in a recent Phase 2 trial. Methods: Between 2003 and 2006 at >20 sites, a total of 3 Phase 1 (solid tumors) and 2 Phase 2 (melanoma, sarcoma) clinical trials of E+P were completed. Various dose regimens were explored, and 1 randomized, blinded study had a paclitaxel control. Exposure, adverse event (AE) and lab data were combined. All AE data were graded per CTCAE v.3 and re-coded to MedDRA 9.0. All treated patients (pts) were analyzed by treatment received. Results: 239 pts received E+P, with 224 receiving E at or above 213 mg/m2, the dose currently under investigation in a Phase 3 trial in metastatic melanoma. Of 269 total treated pts, 62% were male, 89% were Caucasian; mean age = 57. Mean E+P treatment duration = 85 d (range 1 to 554 d). The most frequent AEs for E+P pts were fatigue, alopecia, nausea, constipation, and diarrhea. The most frequent ≥ Grade 3 AEs are presented below; P-alone blinded control data (metastatic melanoma) are given for comparison. Lab data show a small incidence increase in ≥ Grade 3 neutropenia for the E+P group vs. P alone. The most frequent non-neoplastic AEs resulting in E+P discontinuation were hypersensitivity reactions, neuropathic events, and respiratory disorders; comparable %s of P-alone pts discontinued P for these reasons. Conclusions: Given via various dosing regimens to oncology populations, E+P demonstrated small toxicity increases over P alone and was generally well tolerated. Observed E+P toxicities were typical of taxane administration. No ≥ Grade 3 AE exceeded 10%. Slight incidence increases for ≥ Grade 3 neutropenia were observed; a small P-alone sample limits interpretation.
- 20 May 2008
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 26 (15_suppl) , 14595
Integrated safety analysis of elesclomol (formerly STA-4783) co-administered with paclitaxel
14595 Background: Elesclomol is a novel small-molecule oxidative stress inducer known to synergize with taxanes and certain other chemotherapeutics. Co-administered with paclitaxel (E+P), it demonstrated encouraging activity in metastatic melanoma in a recent Phase 2 trial. Methods: Between 2003 and 2006 at >20 sites, a total of 3 Phase 1 (solid tumors) and 2 Phase 2 (melanoma, sarcoma) clinical trials of E+P were completed. Various dose regimens were explored, and 1 randomized, blinded study had a paclitaxel control. Exposure, adverse event (AE) and lab data were combined. All AE data were graded per CTCAE v.3 and re-coded to MedDRA 9.0. All treated patients (pts) were analyzed by treatment received. Results: 239 pts received E+P, with 224 receiving E at or above 213 mg/m2, the dose currently under investigation in a Phase 3 trial in metastatic melanoma. Of 269 total treated pts, 62% were male, 89% were Caucasian; mean age = 57. Mean E+P treatment duration = 85 d (range 1 to 554 d). The most frequent AEs for E+P pts were fatigue, alopecia, nausea, constipation, and diarrhea. The most frequent ≥ Grade 3 AEs are presented below; P-alone blinded control data (metastatic melanoma) are given for comparison. Lab data show a small incidence increase in ≥ Grade 3 neutropenia for the E+P group vs. P alone. The most frequent non-neoplastic AEs resulting in E+P discontinuation were hypersensitivity reactions, neuropathic events, and respiratory disorders; comparable %s of P-alone pts discontinued P for these reasons. Conclusions: Given via various dosing regimens to oncology populations, E+P demonstrated small toxicity increases over P alone and was generally well tolerated. Observed E+P toxicities were typical of taxane administration. No ≥ Grade 3 AE exceeded 10%. Slight incidence increases for ≥ Grade 3 neutropenia were observed; a small P-alone sample limits interpretation.